Loading clinical trials...
Loading clinical trials...
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants
Conditions
Interventions
IPN10200
Placebo
Locations
44
United States
University of Arizona Health Sciences - Neurology
Tucson, Arizona, United States
Parkinson's & Mvmt Disorders Inst
Fountain Valley, California, United States
Parkinson's Ds & Mvt Disorders Cntr
Boca Raton, Florida, United States
USF Health Byrd Alzheimer's Institute
Tampa, Florida, United States
Emory Brain Health Center
Atlanta, Georgia, United States
Rush Medical Center
Chicago, Illinois, United States
Start Date
June 30, 2025
Primary Completion Date
March 26, 2027
Completion Date
November 5, 2027
Last Updated
April 6, 2026
NCT06328114
NCT06748846
NCT02689466
NCT03938363
NCT02504905
NCT05884528
Lead Sponsor
Ipsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions